Stock listing
Chordia Therapeutics Inc.
Selected listing: 190A · TSE · JPY · JP
Chordia Therapeutics Inc. (Tokyo:190A), Health Technology. Latest release Sep 30, 2026: Announcement Regarding AMED Grant Award for rogocekib (CTX-712).
- Ticker
- Tokyo:190A
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Chordia Therapeutics Inc.
Chordia Therapeutics Inc. is a public company listed under the ticker 190A, operating in the Japanese market. Chordia focuses on developing innovative therapeutic solutions to address unmet medical needs.
Latest news from Chordia Therapeutics Inc.
Announcement Regarding AMED Grant Award for rogocekib (CTX-712)
September 29, 2026
Announcement Regarding Completion of Patient Enrollment in the Initial Expansion Cohort of rogocekib
September 24, 2026
Announcement of Orphan Drug Designation in Japan for rogocekib for Relapsed or Refractory AML
August 24, 2026
Announcement Regarding the Review Status of Orphan Drug Designation for Rogocekib, a CLK Inhibitor
July 28, 2026
Notice of Receipt of Grant
July 17, 2026
Research Chordia Therapeutics Inc.
Chordia Therapeutics Inc. company profile
View the public company page for Chordia Therapeutics Inc. on 6ix.
Chordia Therapeutics Inc. news
Read company news and market updates connected to Chordia Therapeutics Inc..
Chordia Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Chordia Therapeutics Inc..